GitLab Cl A saw its IBD SmartSelect Composite Rating jump to 96 Wednesday, up from 91 the day before.
The upgrade means the stock is now outpacing 96% of all other stocks in terms of key performance metrics and technical strength. The market's biggest winners often have a 95 or higher score in the early stages of a new price run, so that's an important benchmark to look for when looking for the best stocks to buy and watch.
GitLab Cl A is not currently near a proper buy zone. Look for the stock to form and break out of a new base.
Lean How — And When — To Sell Stocks
The stock sports an 81 EPS Rating, meaning its recent quarterly and annual earnings growth is outpacing 81% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
The company reported a 156% increase in earnings for Q3. Revenue was flat, matching the prior quarter's 31%.
GitLab Cl A holds the No. 1 rank among its peers in the Computer-Technical Services industry group. Dave and Hewlett Packard Ent are also among the group's highest-rated stocks.
